Compare · ACON vs ELV
ACON vs ELV
Side-by-side comparison of Aclarion Inc. (ACON) and Elevance Health Inc. (ELV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ACON and ELV operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $90.24B, about 10265.7x ACON ($8.8M).
- Over the past year, ACON is down 53.0% and ELV is up 7.4% - ELV leads by 60.4 points.
- ACON has been more active in the news (7 items in the past 4 weeks vs 3 for ELV).
- ELV has more recent analyst coverage (23 ratings vs 0 for ACON).
- Company
- Aclarion Inc.
- Elevance Health Inc.
- Price
- $3.35-4.01%
- $418.31+0.63%
- Market cap
- $8.8M
- $90.24B
- 1M return
- +2.45%
- +12.19%
- 1Y return
- -53.02%
- +7.35%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2022
- News (4w)
- 7
- 3
- Recent ratings
- 0
- 23
Aclarion Inc.
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest ACON
- Aclarion Rejects Echo Lake Capital's Unsolicited Acquisition Proposal
- Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting
- Aclarion Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation
- Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study
- Aclarion, Inc. Comments on Echo Lake Capital's Letter and Unsolicited Proposal
- Echo Lake Capital Offers To Acquire Aclarion Inc.
- SEC Form 10-Q filed by Aclarion Inc.
- Director Breidbart Scott bought $18,012 worth of shares (5,664 units at $3.18) (SEC Form 4)
- Director Neal David K bought $7,750 worth of shares (2,500 units at $3.10), increasing direct ownership by 125,000% to 2,502 units (SEC Form 4)
Latest ELV
- Elevance Health Expands Access to Digital Tools, Helping Bridge the Healthcare Digital Divide
- CAO & Controller Penczek Ronald W exercised 1,531 shares at a strike of $294.30 and sold $617,192 worth of shares (1,531 units at $403.13) (SEC Form 4)
- Elevance Health upgraded by Deutsche Bank with a new price target
- Director Schulman Amy W was granted 563 shares, increasing direct ownership by 258% to 781 units (SEC Form 4)
- Director Schneider Ryan M. was granted 563 shares, increasing direct ownership by 9% to 7,163 units (SEC Form 4)
- Director Peru Ramiro G was granted 563 shares, increasing direct ownership by 6% to 9,908 units (SEC Form 4)
- Director Neri Antonio F was granted 563 shares, increasing direct ownership by 11% to 5,488 units (SEC Form 4)
- Director Jallal Bahija was granted 563 shares, increasing direct ownership by 12% to 5,351 units (SEC Form 4)
- Director Hay Lewis Iii was granted 563 shares, increasing direct ownership by 5% to 12,070 units (SEC Form 4)
- Director Dixon Robert L Jr was granted 563 shares, increasing direct ownership by 5% to 10,885 units (SEC Form 4)